Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
An April study in The Lancet eClinical- Medicine suggested GLP-1 medications may cut some cancer risks in half
Data from FLOW trials of semaglutide demonstrate that semaglutide slows down the progression of chronic kidney disease in diabetics
Why is encapsulation efficiency measurement critical for liposomal drug development
Circ Res (2001) 89:44552
Free consultation is available
US$ 22.59
US$ 24.66
US$ 26.83
US$ 28.73
US$ 27.27
US$ 29.38
US$ 27.25
US$ 19.99
US$ 23.45
US$ 28.21
